Pat Gillespie, Author at Cornell Engineering

Expanded SPROUT Awards maintain engineering innovation momentum

From mapping the human gut-brain connection to creating safer cancer nanotherapies, the latest Expanded SPROUT Awards from Cornell Engineering are exploring breakthroughs in microbiome science, quantum materials and biomedical engineering.

Balancing the promise of health AI with its carbon costs

The health care industry is increasingly relying on AI – in responding to patient queries, for example – and a new Cornell study shows how decision-makers can use real-world data to build sustainability into new systems.

18 Cornellians receive Fulbright awards

Eighteen Cornellians have been offered Fulbright U.S. Student Program awards this academic year.

Research at Risk: Nanoscale facility in funding limbo

The Cornell NanoScale Science and Technology Facility has enabled scientists and engineers from academia and industry to conduct groundbreaking research, thanks to continuous support from the National Science Foundation. But that funding is now at risk.

Cornell’s Ignite Innovation Acceleration program supports inventors, early-stage innovations

Six Cornell inventors developing projects in robotics, advanced materials, agriculture, biotechnology, AI for medical education and veterinary medicine have been selected for the spring 2025 cycle of the Ignite Innovation Acceleration program.

‘Eye-on-a-chip’ reveals trigger for steroid-induced glaucoma

Cornell researchers have identified the signaling mechanism that triggers steroid-induced glaucoma by creating a 3D “eye-on-a-chip” platform that mimics the flow of ocular fluids.

Cornell showcases semiconductor leadership at 2025 SUPREME annual review

Cornell University hosted the 2025 SUPREME annual review, bringing together academia, industry, and government to advance next-generation semiconductor innovation and workforce development.

3D-printed superconductor achieves record performance

Nearly a decade after they first demonstrated that soft materials could guide the formation of superconductors, Cornell researchers have achieved a one-step, 3D printing method that produces superconductors with record properties.

Bioengineered bacteria could lead to therapeutic antibody drugs

A Cornell-led collaboration devised a potentially low-cost method for producing antibodies for therapeutic treatments: bioengineered bacteria with an overlooked enzyme that can help monoclonal antibodies boost their immune defenses.

Mako, a faculty-led startup based at Cornell Tech, raises $8.5 million

Mako, co-founded by assistant professor Mohamed Abdelfattah, sets out to tackle one of artificial intelligence’s most pressing infrastructure challenges: optimizing the computing efficiency of graphics processing units.